unknown
Stage
1
Investors
About
Zenas BioPharma is a clinical-stage biotechnology company developing immune-based therapies focused on autoimmune diseases using investigational drugs such as obexelimab and orelabrutinib.
Explore Zenas Biopharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.